InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Schwartz Elissa J., Director. Insider active across 1 company, notably Galectin Therapeutics INC. Aggregated, 2 reports have been logged. Breakdown: 2 buys · 0 sell. Total volume traded: €4k. History available since 21 January 2022. The latest transaction was filed on 21 January 2022 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations2 total
1,000 shares@ US$2.000.0012% mcap50.0% of flowCommon StockSEC:0001133416-22-000012:0
Ideal exit: 18 Oct 2022 (T+270)
1,000 shares@ US$2.00100.0% of flowCommon StockSEC:0001133416-22-000012
Ideal exit: 18 Oct 2022 (T+270)
2 of 2 declarations
About Schwartz Elissa J.
Elissa J. Schwartz is a Director at GALECTIN THERAPEUTICS INC. She is involved in strategic decision-making and overseeing the company's activities. Her experience and knowledge of the industry are valuable assets in guiding GALECTIN THERAPEUTICS towards its goals.
